Athayde C

No ORCID on file · 6 papers in corpus · active 2003-2008

Study types

  • article 5
  • other 1

Condition tags

  • endometriosis 5
  • adenomyosis 4
article 2008
Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies
Contraception ·doi:10.1016/j.contraception.2008.07.002

BackgroundThe study was conducted to evaluate vascular endothelial growth factor (VEGF), Cox-2 and aromatase expression in the endometrium of uteri with myomas and other associated pathologies.Study designHysteroscopy was performed in 118 w…

article 2008
The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590801890816

OBJECTIVE: To determine the effect of oral contraceptives containing gestodene on aromatase expression in the endometrium of patients diagnosed with endometriosis. PATIENTS AND METHODS: Endometrial biopsies were taken at the time of laparos…

article 2006
Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590601005375

OBJECTIVES: To determine whether aromatase expression in the eutopic endometrium and adenomyotic foci is affected by previous use of oral contraceptives containing gestodene, and to determine whether changes in cyclooxygenase-2 (COX-2) expr…

article 2005
Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590400021086

OBJECTIVE: To study the expression of proliferation markers (ki-67) and anti-apoptotic protein (bcl-2) in adenomyotic lesions during the menstrual cycle or following the use of steroid hormones. PATIENTS AND METHODS: Ninety patients of repr…

other 2004
Proliferation kinetics in adenomyosis during the menstrual cycle and during oral contraceptive use
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590310001652982

Our objective was to investigate the presence of focal p53 expression in relation to proliferation rates in adenomyotic lesions during the menstrual cycle and in women on oral contraception. Fifty-nine perimenopausal patients with menorrhag…

article 2003
Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(05)60158-2

Study objectiveTo evaluate the efficacy of Mirena, a levonorgestrel-releasing intrauterine device, after endometrial resection for treatment of menorrhagia caused by adenomyosis.DesignOpen, randomized, observational study (Canadian Task For…